Completed PHASE2 INTERVENTIONAL 8-arm NCT00903617

Study to Test GSK256073 in Patients With Dyslipidemia

A Two Part, Multicenter Phase IIa, Placebo Controlled Study, to Examine the Safety, Tolerability, and Effects of GSK256073 on Lipids in Subjects With Dyslipidemia

Sponsor: GlaxoSmithKline

Conditions Dyslipidaemias Dyslipidemias

Interventions GSK256073 Niaspan Placebo

Updated 9 times since 2017 Last updated: Nov 19, 2019 Started: Jun 15, 2009 Primary completion: Feb 16, 2010 Completion: Feb 16, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00903617, this PHASE2 trial focuses on Dyslipidaemias and Dyslipidemias and remains completed. Sponsored by GlaxoSmithKline, it has been updated 9 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Dec 2021 — Jul 2024 [monthly]

Completed PHASE2
Jan 2021 — Dec 2021 [monthly]

Completed PHASE2
Jan 2020 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 4 earlier versions

Jun 2018 — Jan 2020 [monthly]

Completed PHASE2
Oct 2017 — Jun 2018 [monthly]

Completed PHASE2
Feb 2017 — Oct 2017 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Jun 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

GlaxoSmithKline

Data source: GlaxoSmithKline

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Auburn, United States , Brooklyn Center, United States , Cincinnati, United States , Indianapolis, United States , Louisville, United States , Olympia, United States , Pembroke Pines, United States , Richmond, United States , San Antonio, United States , Seattle, United States and 1 more location